TRAMETINIB DIMETHYL SULFOXIDE for Metastatic malignant melanoma: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 2,031 adverse event reports in the FDA FAERS database where TRAMETINIB DIMETHYL SULFOXIDE was used for Metastatic malignant melanoma.
Most Reported Side Effects for TRAMETINIB DIMETHYL SULFOXIDE
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 2,998 | 18.4% | 2,989 | 176 |
| Pyrexia | 2,660 | 16.3% | 242 | 978 |
| Rash | 1,271 | 7.8% | 77 | 213 |
| Fatigue | 1,143 | 7.0% | 106 | 243 |
| Malignant neoplasm progression | 1,114 | 6.8% | 430 | 319 |
| Nausea | 1,085 | 6.7% | 112 | 300 |
| Chills | 965 | 5.9% | 55 | 278 |
| Diarrhoea | 867 | 5.3% | 72 | 268 |
| Vomiting | 720 | 4.4% | 78 | 313 |
| Product use in unapproved indication | 687 | 4.2% | 133 | 88 |
| Malaise | 547 | 3.4% | 77 | 197 |
| Headache | 528 | 3.2% | 48 | 146 |
| Visual impairment | 520 | 3.2% | 26 | 67 |
| Asthenia | 473 | 2.9% | 84 | 198 |
| Decreased appetite | 421 | 2.6% | 78 | 149 |
Other Indications for TRAMETINIB DIMETHYL SULFOXIDE
Product used for unknown indication (4,840)
Malignant melanoma (3,841)
Lung neoplasm malignant (589)
Thyroid cancer (482)
Non-small cell lung cancer (386)
Neoplasm malignant (362)
Brain neoplasm malignant (317)
Ovarian cancer (282)
Malignant melanoma stage iv (147)
Lung carcinoma cell type unspecified stage 0 (136)
Other Drugs Used for Metastatic malignant melanoma
NIVOLUMAB (4,628)
IPILIMUMAB (4,430)
DABRAFENIB (3,885)
PEMBROLIZUMAB (2,742)
VEMURAFENIB (1,848)
TRAMETINIB (1,604)
COBIMETINIB (898)
ENCORAFENIB (865)
BINIMETINIB (841)
TALIMOGENE LAHERPAREPVEC (157)